PharmaQMtraining.eu


Our Core Panel of Speakers

FULL DETAILS

Graham Buckton
BPharm PhD DSc AKC
FRPharmS CChem FRSC

Graham Buckton is Professor of Pharmaceutics at the School of Pharmacy University of London and is Chief Executive Officer of Pharmaterials Limited

He is a Member of the Expert Advisory Group (EAG) on Pharmacy and Standards that advises the Commission on Human Medicines, a Member of the British Pharmacopoeia ommission (BPC), a Member of the BPC EAG on Pharmacy and Chairman of the BPC Working Party on Excipients MORE

Previous page
return to ABOUT US page

Derek Calam
MA DPhil CChem
FRSC Hon MRPharmS

Derek Calam is a Visiting Professor of Pharmaceutical Sciences, University of Strathclyde

He is a Member of the WHO Expert Panels for both Pharmaceuticals and Biologicals and Chairman of the WHO Committee responsible for allocating names to names to medical substances on a global basis and he is a UK-nominated Expert at the European Medicines Evaluation Agency (EMEA) in London MORE

Previous page
return to ABOUT US page

Hugh Delargy
BSc MSc PhD
MRPharmS
MTOPRA

Hugh Delargy is a registered pharmacist, international lecturer and scientific author and a Quality Assessor on the WHO Prequalification Programme (Geneva – Copenhagen) 

He is an experienced pharmaceutical regulatory consultant with both industrial development and regulatory assessment experience of medicines for clinical trial approvals and marketing authorisations in the EU MORE

Previous page
return to ABOUT US page

Paul Fleming
BSc MSc MRPharmS

Paul Fleming is Technical Director of the British Generic Manufacturers Association (BGMA). BGMA represents and promotes the views of the generic medicines industry in UK and has close and regular discussions with MHRA, other parts of the Department of Health and the NHS.  At a European level, he is a key Member of the Regulatory Committee of the European Generic Manufacturers Association, EGA.  In both these roles, Paul is involved in the development and implementation of new regulatory guidance.

Paul has spent 15 years working for the generic sector of the pharmaceutical industry in Europe in a variety of senior board level roles covering drug regulation, pharmacovigilance and formulation development.  In the 1990s he spent six years with the MHRA as a Pharmaceutical Assessor and still holds a formal position as an Expert to the British Pharmacopoeia Commission.  He is an experienced and accomplished Lecturer.MORE

Previous page
return to ABOUT US page

Chris Marriott
PhD DSc FRPharmS
CChem FRSC FRSM

Chris Marriott is Emeritus Professor of Pharmaceutics in the School of Pharmacy, King’s College, University of London

He is a Fellow of the Royal Society of Chemistry (1981), a Fellow of the Royal Pharmaceutical Society (1984) and a Fellow of the Royal Society of Medicine (2009), an international lecturer and scientific author of more than 200 original papers focused largely on inhalation and dermal drug delivery systems

He is a Member of the Expert Advisory Group (EAG) on Pharmacy and Standards that advises the Commission on Human Medicines

He is a consultant to the pharmaceutical industry and holds Directorships at MedPharm Ltd and Remedica Ltd MORE

Previous page
return to ABOUT US page

Geoff Mellor

Geoff Mellor is Technical Director of the British Association of Pharmaceutical Wholesalers (BAPW) which represents full-line pharmaceutical wholesalers in the UK. BAPW is a Member of the Brussels based European Association of Pharmaceutical Full-line Wholesalers, the GIRP. MORE

Previous page
return to ABOUT US page

Carl Mroz

Carl Mroz is currently the Director of Global Regulatory Affairs, EMEA for Colorcon Limited in the UK.

He is an active member of the International Pharmaceutical Excipients Council (IPEC) Europe, as the Chair of the Quality and Regulatory Affairs Committee and is also a member of the European Pharmacopoeia Working Party on Functionality Related Characteristics, a member of the British Pharmacopoeia Working Party on Excipients and the Panel of Experts on Inorganic Chemicals. MORE

Previous page
return to ABOUT US page

Mark Richardson
PhD FTOPRA

Mark Richardson is an independent consultant in drug development regulatory affairs for small molecule, biotech and advanced therapy products for clients in Europe, the US and the Asia-Pacific region. MORE

Previous page
return to ABOUT US page



Steve Porter is a highly experienced Quality Professional with over 35 years’ service in the Pharmaceutical Industry. He is currently a Company Director at Steve Porter Pharma Consulting providing services in internal and supplier auditing, quality system design and enhancement, regulatory inspection preparations and remedial actions, design and delivery of training courses, supply chain design and evaluation, and QP services.

Steve has extensive auditing experience in the US, Europe and Asia (China, India, Japan). He has also served as a Board Member of IPEC Europe. He is an experienced International lecturer.

Steve is a Fellow of the Royal Society of Chemistry.

Until recently he was QA Director (Compliance), Global External Sourcing at Astra Zeneca. His many duties there included involvement with the company’s preparations for compliance with the Falsified Medicines Directive.

Previous page
return to ABOUT US page

Dr Mike Robertson
BPharm PhD MRPharmS
CChem MRSC CSci FTOPRA

View Mike Robertson's profile on LinkedIn

Mike Robertson designs our courses and he has created over 100 public conferences for various conference providers and he has written and personally delivered hundreds of lectures for public and professional organisations in Europe and North America

He is a Visiting Lecturer at King's College, University of London

He is a Quality Assessor on the WHO Prequalification Programme (Geneva – Copenhagen) and he also writes scientific papers on CMC subjects MORE

Previous page
return to ABOUT US page

favicon

David Snodin
BSc ARCS PhD MChemA MSc (Toxicology) MSc (Applied Statistics) FRSC MTOPRA

David Snodin is Principal, Xiphora Bipharma Consulting. He is a Fellow of the Royal Society of Chemistry, a Member of The Organisation for Professionals in Regulatory Affairs and a Registered Euro Toxicologist

He is an experienced international lecturer and author of many scientific papers on Safety Evaluation of Biopharmaceuticals and specialises particularly on carcinogenicity and genotoxicity issues in medicines development MORE

Previous page
return to ABOUT US page


Links | Privacy Policy | Terms & Conditions | Contact| Facebook LindeIn youtube Twitter